WallStreetZen

NYSE: MRK
Merck & Co Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for MRK

Based on 5 analysts offering 12 month price targets for Merck & Co Inc.
Min Forecast
$92.00+20.56%
Avg Forecast
$99.40+30.26%
Max Forecast
$105.00+37.6%

Should I buy or sell MRK stock?

Strong Buy
Strong Buy
3 analysts 50%
Buy
2 analysts 33.33%
Hold
1 analysts 16.67%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

MRK stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDate
Chris Schott
JP Morgan
Strong BuyMaintains$105.00+37.60%2020-10-16
Terence Flynn
Goldman Sachs
Strong BuyUpgrades$105.00+37.60%2020-08-03
Navin Jacob
UBS
Strong BuyMaintains$92.00+20.56%2020-04-13
Anonymous
Bernstein
BuyReinstates$95.00+24.49%2020-11-10
Daina Graybosch
SVB Leerink
BuyMaintains$100.00+31.04%2020-08-25
Tim Anderson
Wolfe Research
HoldDowngradesN/AN/A2020-06-12

1 of 1

Forecast return on equity

Is MRK forecast to generate an efficient return?
Company
78.6%
Industry
76.5%
Market
32,279.67%
MRK's Return on Equity is forecast to be high in 3 years (78.6%); analysts are confident in the firm's ability to efficiently generate return on equity
Forecast

Forecast return on assets

Is MRK forecast to generate an efficient return on assets?
Company
21.73%
Industry
16.91%
Market
11,627.87%
MRK is forecast to generate higher Return on Assets (21.73%) than the US Drug Manufacturers - General industry average (16.91%)
Forecast

MRK earnings per share forecast

What is MRK's earnings per share in the next 3 years based on estimates from 7 analysts?
Avg 1 year Forecast
$6.56+135.08%
Avg 2 year Forecast
$6.96+149.46%
Avg 3 year Forecast
$7.43+166.4%
MRK's earnings are forecast to grow at an exceptional rate of 38.52% per year
Forecast

MRK revenue forecast

What is MRK's revenue in the next 3 years based on estimates from 4 analysts?
Avg 1 year Forecast
$52.1B+8.49%
Avg 2 year Forecast
$54.2B+12.95%
Avg 3 year Forecast
$55.8B+16.25%
MRK's revenue is forecast to grow at a rate of 5.15% per year, which is not exceptional
Forecast

MRK earnings growth forecast

How is MRK forecast to perform vs Drug Manufacturers - General companies and vs the US market?
Company
38.52%
Industry
34.05%
Market
23.11%
MRK's earnings are forecast to grow faster (38.52% per year) than the US Drug Manufacturers - General industry average (34.05%)
Forecast
MRK's earnings are forecast to grow faster (38.52% per year) than the US market average (23.11%)
Forecast
MRK's earnings are forecast to grow faster (38.52% per year) than the risk-free savings rate (1.7%)
Forecast

MRK revenue growth forecast

How is MRK forecast to perform vs Drug Manufacturers - General companies and vs the US market?
Company
5.15%
Industry
6.04%
Market
15.04%
MRK's revenues are forecast to grow slower (5.15% per year) than the US Drug Manufacturers - General industry average (6.04%)
Forecast
MRK's revenues are forecast to grow slower (5.15% per year) than the US market average (15.04%)
Forecast

Merck & Stock Forecast FAQ

Is Merck & Stock a good buy in 2021, according to Wall Street analysts?

The consensus among 6 Wall Street analysts covering (NYSE: MRK) stock is to Strong Buy MRK stock.

Out of 6 analysts, 3 (50%) are recommending MRK as a Strong Buy, 2 (33.33%) are recommending MRK as a Buy, 1 (16.67%) are recommending MRK as a Hold, 0 (0%) are recommending MRK as a Sell, and 0 (0%) are recommending MRK as a Strong Sell.

What is MRK's earnings growth forecast for 2021-2023?

(NYSE: MRK) Merck &'s forecast annual earnings growth rate of 38.52% is forecast to beat the US Drug Manufacturers - General industry's average forecast earnings growth rate of 34.05%, and and it is also forecast to beat the US market's average forecast earnings growth rate of 23.11%.

Merck &'s earnings in 2021 is $7,067,000,000.On average, 7 Wall Street analysts forecast MRK's earnings for 2021 to be $16,593,483,859, with the lowest MRK earnings forecast at $16,394,623,152, and the highest MRK earnings forecast at $16,748,827,973. On average, 6 Wall Street analysts forecast MRK's earnings for 2022 to be $17,609,039,682, with the lowest MRK earnings forecast at $15,180,206,622, and the highest MRK earnings forecast at $19,076,459,655.

In 2023, MRK is forecast to generate $18,804,480,953 in earnings, with the lowest earnings forecast at $16,369,322,807 and the highest earnings forecast at $20,316,176,529.

What is MRK's revenue growth forecast for 2021-2023?

(NYSE: MRK) Merck &'s forecast annual revenue growth rate of 5.15% is not forecast to beat the US Drug Manufacturers - General industry's average forecast revenue growth rate of 6.04%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 15.04%.

Merck &'s revenue in 2021 is $47,994,000,000.On average, 4 Wall Street analysts forecast MRK's revenue for 2021 to be $131,740,803,310,590, with the lowest MRK revenue forecast at $130,919,971,588,022, and the highest MRK revenue forecast at $133,013,271,480,507. On average, 4 Wall Street analysts forecast MRK's revenue for 2022 to be $137,156,562,135,984, with the lowest MRK revenue forecast at $125,471,997,834,141, and the highest MRK revenue forecast at $144,513,037,007,003.

In 2023, MRK is forecast to generate $141,155,934,312,548 in revenue, with the lowest revenue forecast at $128,973,565,494,949 and the highest revenue forecast at $149,389,248,278,466.

What is MRK's forecast return on assets (ROA) for 2021-2024?

(NYSE: MRK) forecast ROA is 21.73%, which is higher than the forecast US Drug Manufacturers - General industry average of 16.91%.

What is MRK's Price Target?

According to 5 Wall Street analysts that have issued a 1 year MRK price target, the average MRK price target is $99.40, with the highest MRK stock price forecast at $105.00 and the lowest MRK stock price forecast at $92.00.

On average, Wall Street analysts predict that Merck &'s share price could stay at $99.40 by Nov 10, 2021. The average Merck & stock price prediction forecasts a potential downside of N/A from the current MRK share price of $76.31.

What is MRK's Earnings Per Share (EPS) forecast for 2021-2023?

(NYSE: MRK) Merck &'s current Earnings Per Share (EPS) is $2.79. On average, analysts forecast that MRK's EPS will be $6.56 for 2021, with the lowest EPS forecast at $6.48, and the highest EPS forecast at $6.62. On average, analysts forecast that MRK's EPS will be $6.96 for 2022, with the lowest EPS forecast at $6.00, and the highest EPS forecast at $7.54. In 2023, MRK's EPS is forecast to hit $7.43 (min: $6.47, max: $8.03).

What is MRK's forecast return on equity (ROE) for 2021-2024?

(NYSE: MRK) forecast ROE is 78.6%, which is considered strong.
©2021 WallStreetZen
Company
AboutBlogPrivacy PolicyTerms of ServiceContact
Stocks
Stock ScreenerStock ForecastHighest Earnings StocksBest Dividend Paying StocksStatisticsTrending Stocks
Social
TwitterYouTube
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.